Archived explainer. For the current picture see today's SYK page.
STRYKER CORP (SYK) is up +4.96% in the latest session. Our newswire has captured 1 story on SYK across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 63/100).
SYK stock is up 4.96% to $332.06 on Friday morning, driven by news from Stryker Corp about a major product expansion. The company announced the U.S. commercial launch of Mako RPS, a new handheld robotic technology that expands the Mako platform and brings robotic-assisted knee replacement to a new orthopaedic market segment. The stock opened at $316.00 and reached an intraday high of $332.13 at 9:40 AM ET.
Stryker Corp announced the full market release of its Mako RPS technology, a development that marks a significant expansion of its Mako robotics portfolio. The new offering is designed to enhance the company's robotic-assisted knee replacement capabilities and reach a broader patient population. This product launch is expected to strengthen Stryker's position in the orthopaedics market and drive future growth. The move comes as BMO Capital initiated coverage on the stock with an Outperform rating and a $369 price target, and as Evercore ISI Group maintained its Outperform rating with a revised $350 price target.
The stock has a market cap of $127.1 billion and a P/E ratio of 36.6. Trailing twelve-month revenue grew 8.8% with a net margin of 13.2%. The stock traded at a volume of 0.1 million shares so far, which is 0.0 times the 3-month daily average. The price has been volatile over the past 52 weeks, ranging from $281.00 to $404.87. Over the last eight sessions, the stock fell 1.4% from $321.05 to $316.44 before today's sharp reversal. Recent insider transactions include three sales totaling $100.7 million over the last 90 days, with no insider purchases reported.
Investors should monitor the breadth of analyst coverage and any follow-up reports from BMO Capital and Evercore ISI Group. The stock's performance will also depend on how the market receives the Mako RPS product rollout and broader adoption trends in robotic-assisted orthopaedics.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Not financial advice.
New handheld robotic technology expands the Mako platform and brings Mako robotic-assisted knee replacement to a new segment of the orthopaedic market Stryker announced the U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement procedures. The launch...
More on SYK: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier SYK move explainers: 2026-07-16